BioCentury
ARTICLE | Company News

Pfizer sales and marketing update

January 21, 2013 8:00 AM UTC

Pfizer launched Quillivant XR in the U.S. to treat ADHD. FDA approved the once-daily, extended-release liquid methylphenidate last September. Quillivant XR was developed using drug delivery technolog...